OIE Mentor Supports Innovators’ Growth and Potential
Office of Innovation and Entrepreneurship 2025 James “Chip” Hanlon Volunteer Mentor of the Year:... Read more
The program, a collaboration between Pitt’s Office of Innovation and Entrepreneurship (OIE) and the Office of the Senior Vice Chancellor for the Health Sciences, is part of the University’s larger initiative to bring ideas and discoveries identified in the lab closer to products and treatments for patients.
Awards are granted in amounts of up to $50K to test scientific hypotheses addressing unmet needs or challenges in human health and disease with a commercial endpoint.

The program is open to University faculty, postdocs, students, and staff in Pitt’s Schools of the Health Sciences and offers funding, community, and a simplified process to enter ideas into the commercialization pathway. By kickstarting the testing of ideas, Pitt.INC adds value to innovators and boosts their potential for successful commercialization and societal impact.
Eligible applications do not have an invention disclosure on file with OIE, or if you have submitted an invention disclosure, no patent applications have been filed.
About Pitt.INC
Funds from Pitt.INC may only be used for the direct costs of the activities outlined in the approved project plan and budget.
Eligible expenses include:
Ineligible expenses include:
Previous Awardees
Project Title: Rebuilding Neurons: A novel target as a therapeutic candidate in CTE
Summary: Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative
disease caused by repeated head trauma, with no current treatments targeting the
underlying dysfunction. This project proposes targeting a specific protein as a novel
therapeutic approach to restore neuronal integrity in CTE. Preliminary data suggest that
enhancing this protein may counteract neuronal damage and support central nervous
system function.
Project Title: Neuroimmune modulation for neurodegenerative therapy
Summary: Neurodegenerative diseases, including Alzheimer’s and HIV-associated
cognitive decline, are rapidly increasing and share a common driver: chronic
neuroinflammation. This project introduces a novel therapeutic platform to target
inflammation in the brain, promoting a neuroprotective and anti-inflammatory response.
Through modulation of central nervous system immune function, this approach offers a firstin-class solution across multiple neuroinflammatory conditions.
Project Title: GeniX: Generative AI platform for personalized clinical certification exam
Summary: Clinical programs rely on national certification exams, but current test
preparation methods are time-intensive for faculty and lack personalized, data-driven
support for students. GeniX is an AI-powered platform that tailors practice questions and
tutoring based on individual student needs, aiming to improve exam pass rates. GeniX offers
a scalable, cost-effective solution for clinical education programs across multiple
healthcare disciplines.
Project Title: Objective test for diagnosis of pulpitis
Summary: Root canal treatments often lead to long-term tooth loss, especially in
adolescents, due to unreliable diagnostics that fail to distinguish between reversible and
irreversible pulpitis. This project aims to develop an objective test of inflamed tooth pulp to
guide treatment decisions and preserve dental health. Using cutting-edge precise,
personalized diagnostics, this approach would revolutionize dental care by preserving tooth
vitality and reducing unnecessary root canals.
Project Title: Evaluating novel exosomes as a therapeutic candidate for Meniere’s Disease
Summary: Meniere’s disease is a chronic inner ear disorder characterized by vertigo, hearing
loss, and tinnitus, with no FDA-approved disease-modifying treatments. This project
proposes using a novel therapy to reduce proinflammatory signaling and restore inner ear
structural integrity. As a first-in-class therapy, this approach offers a more effective and safer
alternative to current symptom-focused treatments for an underserved patient population.
Project Title: Novel therapeutic strategy for chronic kidney disease
Summary: Chronic kidney disease (CKD) affects over 37 million U.S. adults and is
associated with multiple co-morbidities, creating a significant healthcare burden and
highlighting the need for more effective treatments. This project explores a novel therapeutic
approach to restore cellular function and slow CKD progression. This solution could lead to
a first-in-class therapeutic platform for treating CKD and other metabolic diseases.